Rights and permissions About this article Cite this article Madhu, Sharma, A., Kaur, A
It should also be mentioned how new ancillary therapies that have shown very favourable effects even in patients with HF are able to significantly reduce the LD required to maintain effective decongestion, as shown in the STEP-HF and STEP-HF-DM studies
10.1016/j.bbagen.2013.02.009 17 GoY.-M.JonesD
Glutathione neutralizes free radicals
These medications are manufactured by pharmaceutical companies (Novo Nordisk for semaglutide products, Eli Lilly for tirzepatide), have completed extensive clinical trials, and are FDA-approved for their specific indications
Effect of the Glucagon-like Peptide-1 Analogue Liraglutide on Coronary Microvascular Function in Patients with Type 2 Diabetes - a Randomized, Single-Blinded, Cross-Over Pilot Study